MUSTANG BIO, INC. (MBIO) Free cash flow 2017–2024
MUSTANG BIO, INC. (MBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.4MFY2024 · since FY2017: -$13.4M → -$11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$11.4M | +77.0% |
| FY2023 | -$49.5M | +26.9% |
| FY2022 | -$67.8M | -17.6% |
| FY2021 | -$57.7M | -46.9% |
| FY2020 | -$39.2M | -9.2% |
| FY2019 | -$35.9M | -37.6% |
| FY2018 | -$26.1M | -95.3% |
| FY2017 | -$13.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice